The Middle East and Africa laboratory developed test market is expected to reach US$ 869.59 million by 2028 from US$ 577.05 million in 2021; it is estimated to grow at a CAGR of 7.0% from 2021to 2028.
The continuous research on personalized medicine and rising automation of laboratory processes across the globe are factors propelling the laboratory developed testing market. However, the changing regulatory landscape is hampering the growth of the Middle East and Africa laboratory development test market. LDTs play a vital role in developing personalized medicines that are likely to prove as promising means of tackling diseases through far eluded effective treatments or cures. As per the Personalized Medicine Coalition, personalized medicines accounted for only 5% of the new FDA-approved molecular entities in 2005; however, in 2016, this number rose to more than 25%. Additionally, 42% of all compounds and 73% of oncology compounds in the pipeline have the potential to serve as personalized medicines. Biopharmaceutical companies have nearly doubled their R&D investments in personalized drugs in the last five years across the globe. They are further expected to increase their investments by 33% in the next five years. Biopharmaceutical researchers also predict a 69% increase in the development of personalized medicines in the next five years. Personalized medicines are becoming the trademark of cancer treatment; it is a constantly emerging approach based on the customization of treatments per the individual genetic structure. In 2019, the FDA approved 12 personalized medications to investigate and address the root causes of disease; thus, combining precision medicine in clinical care. The rising demand for personalized medicine is, therefore, offering significant growth opportunities for the players operating in the MEA laboratory developed test market. Also, automation is emerging as an approach to minimize human involvement in laboratory processes boosting market growth.
Economic uncertainties and ongoing conflicts are worsening the condition in the Middle East. For instance, countries such as Syria, Libya, and Yemen are suffering violent conflict and are unable to implement any public health measures. A sudden drop in domestic and external demand for goods and products, especially crude oil, and halted production due to labor shortage are significant impacts observed in the region. Additionally, tightened financial condition is decreasing the economic activities in Middle East. Thus, negatively impacting the growth of the laboratory developed test in the region.

- This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
MIDDLE EAST AND AFRICA LABORATORY DEVELOPED TEST MARKET SEGMENTATION
By Type
- Clinical Biochemistry
- Critical Care
- Haematology
- Coagulation and Hemostasis,
- Hemoglobin Testing
- Blood Count Testing
- Others
- Immunology
- Microbiology
- Molecular Diagnostics
- Other Test Types
By Application
- Academic Institutes
- Clinical Research organizations
- Hospitals laboratory
- Specialty Diagnostic Centers
- Others
By Country
- UAE
- Saudi Arabia
- South Africa
- Rest of Middle East and Africa
Company Profiles
- Quest Diagnostics Incorporated
- F. HOFFMANN-LA ROCHE LTD.
- QIAGEN
- Illumina, Inc.
- Rosetta Genomics Ltd.
Middle East and Africa Laboratory Developed Test Report Scope
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 577.05 Million |
Market Size by 2028 | US$ 869.59 Million |
Global CAGR (2021 - 2028) | 7.0% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By Type
|
Regions and Countries Covered | Middle East and Africa
|
Market leaders and key company profiles |
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset


- Non-Emergency Medical Transportation Market
- Nitrogenous Fertilizer Market
- Online Recruitment Market
- Sweet Potato Market
- Animal Genetics Market
- Online Exam Proctoring Market
- Water Pipeline Leak Detection System Market
- Mesotherapy Market
- Bioremediation Technology and Services Market
- Industrial Valves Market

Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
This text is related
to segments covered.

Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
This text is related
to country scope.
Trends and growth analysis reports related to Life Sciences : READ MORE..
- Quest Diagnostics Incorporated
- F. HOFFMANN-LA ROCHE LTD.
- QIAGEN
- Illumina, Inc.
- Rosetta Genomics Ltd.